Spots Global Cancer Trial Database for tcc
Every month we try and update this database with for tcc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto | NCT05874921 | Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Canc... Urothelial Carc... Carcinoma, Tran... Transitional Ce... | Jelmyto (mitomy... | 18 Years - | UroGen Pharma Ltd. | |
| Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based Chemotherapy | NCT01856101 | Carcinoma Trans... | BEZ235 | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma | NCT02401542 | Locally Advance... Urinary Bladder... Urological Dise... | Vofatamab Docetaxel Placebo | 18 Years - | Rainier Therapeutics | |
| A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy | NCT00714025 | Transitional Ce... | RAD001 | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy | NCT02145390 | Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive... | Transurethral R... Intensity Modul... Expanded Prosta... International P... | 18 Years - | University of Miami | |
| Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based Chemotherapy | NCT01856101 | Carcinoma Trans... | BEZ235 | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC | NCT00859339 | Transitional Ce... | Gemcitabine Cisplatin Sunitinib Malat... Radical Cystect... | 18 Years - | Hoosier Cancer Research Network | |
| Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy | NCT02145390 | Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive... | Transurethral R... Intensity Modul... Expanded Prosta... International P... | 18 Years - | University of Miami | |
| The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer | NCT04671407 | TCC | Hypertonic Sali... | 18 Years - 99 Years | Kaplan Medical Center | |
| Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium | NCT00756639 | Bladder Cancer | Prophylactic Cr... Brain X-ray | 18 Years - | M.D. Anderson Cancer Center | |
| Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium | NCT00756639 | Bladder Cancer | Prophylactic Cr... Brain X-ray | 18 Years - | M.D. Anderson Cancer Center | |
| Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium | NCT00756639 | Bladder Cancer | Prophylactic Cr... Brain X-ray | 18 Years - | M.D. Anderson Cancer Center | |
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer | NCT01563796 | Hematuria Dysuria Bladder Cancer | 25 Years - | Medical Diagnostic Laboratories, LLC | ||
| Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection | NCT04147182 | TCC | Hypertonic Sali... | 18 Years - | Kaplan Medical Center | |
| Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC | NCT00859339 | Transitional Ce... | Gemcitabine Cisplatin Sunitinib Malat... Radical Cystect... | 18 Years - | Hoosier Cancer Research Network | |
| Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors | NCT00567684 | Bladder Cancer | Computed Tomogr... Intravenous Uro... | 18 Years - | M.D. Anderson Cancer Center | |
| Efficacy and Safety of UGN-101 in Recurrent Patients | NCT04006691 | Carcinoma Transitional Ce... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer | NCT01563796 | Hematuria Dysuria Bladder Cancer | 25 Years - | Medical Diagnostic Laboratories, LLC | ||
| A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) | NCT05121948 | Squamous Cell C... Colo-rectal Can... Non Small Cell ... Transitional Ce... Other Solid Tum... Clear Cell Rena... | HC-7366 | 18 Years - | HiberCell, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
